1. Furst DE, Ulrich RW, Varkey-Altamirano C. Nonsteroidal Anti-Inflammatory Drugs, Disease Modifying Antirheumatic Drugs, Nonopioids Analgesics, & Drugs Used in Gout. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. Page: 626.
2. Grosser T, Smyth E, FitzGerald GA. Anti-Inflammatory, Antipyretic, and Analgesic Agents; Pharmacotherapy of Gout. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. Page - 986-987.
3. Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. Page: 295-297.
4. B H McCarberg and C E Argoff. Topical diclofenac epolamine patch 1.3% for treatment of acute pain caused by soft tissue injury: International journal of clinical practice. Oct 2010; [Accessed on Jan 19, 2021] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2984542/
5. Priyanka Kriplani, Abhishek Sharma, Aman, Pooja Pun, Bhawna Chopra, Ashwani Dhingra and Geeta. Formulation and Evaluation of Transdermal Patch of Diclofenac Sodium. Volume 4 Issue 5 – Feb 2018; [Accessed on Jan 19, 2021] https://juniperpublishers.com/gjpps/pdf/GJPPS.MS.ID.555647.pdf
6. GlaxoSmithKline Consumer Healthcare (UK) Limited, Electronic Medicines Compendium (EMC); [Revised on Aug 2019] [Accessed on Jan 19, 2021] https://www.medicines.org.uk/emc/files/pil.6992.pdf
7. AstraZeneca Pharmaceuticals LP, 2009; U.S. Food & Drug Administration; http://www.zuventus.co.in/doctor_wise_products_selected.aspx?Medi_Id=306